BioHarvest Sciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Agricultural Commodities/Milling
  • ISIN: CA09076J1084
CAD
7.95
7.85 (7478.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

300

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

0

Held by 0 DIIs

Promoter

32.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Agricultural Commodities/Milling

stock-summary
Market cap

CAD 361 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

3.75

stock-summary
Return on Equity

-920.98%

stock-summary
Price to Book

188.78

Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Mar 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7166.91%
0%
7166.91%
6 Months
7036.45%
0%
7036.45%
1 Year
6015.38%
0%
6015.38%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

BioHarvest Sciences, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
104.25%
EBIT Growth (5y)
-217.30%
EBIT to Interest (avg)
-4.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.75
Sales to Capital Employed (avg)
0.11
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
188.78
EV to EBIT
-38.45
EV to EBITDA
-46.85
EV to Capital Employed
40.56
EV to Sales
10.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-105.48%
ROE (Latest)
-920.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 56.94% vs 148.28% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 61.80% vs -790.00% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.30",
          "val2": "7.20",
          "chgp": "56.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.90",
          "val2": "-1.60",
          "chgp": "-18.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "7.00",
          "chgp": "-88.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.40",
          "val2": "-8.90",
          "chgp": "61.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-218.70%",
          "val2": "-266.50%",
          "chgp": "4.78%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 101.75% vs 137.50% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.12% vs -16.44% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.50",
          "val2": "17.10",
          "chgp": "101.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.90",
          "val2": "-12.30",
          "chgp": "35.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "1.40",
          "chgp": "85.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.80",
          "val2": "-1.40",
          "chgp": "-242.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.70",
          "val2": "-17.00",
          "chgp": "-4.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-277.50%",
          "val2": "-786.50%",
          "chgp": "50.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoYstock-summary
Mar'25
Mar'24
Change(%)
Net Sales
11.30
7.20
56.94%
Operating Profit (PBDIT) excl Other Income
-1.90
-1.60
-18.75%
Interest
0.80
7.00
-88.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.40
-8.90
61.80%
Operating Profit Margin (Excl OI)
-218.70%
-266.50%
4.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2025 is 56.94% vs 148.28% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 61.80% vs -790.00% in Mar 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
34.50
17.10
101.75%
Operating Profit (PBDIT) excl Other Income
-7.90
-12.30
35.77%
Interest
2.60
1.40
85.71%
Exceptional Items
-4.80
-1.40
-242.86%
Consolidate Net Profit
-17.70
-17.00
-4.12%
Operating Profit Margin (Excl OI)
-277.50%
-786.50%
50.90%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 101.75% vs 137.50% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -4.12% vs -16.44% in Dec 2023

stock-summaryCompany CV
About BioHarvest Sciences, Inc. stock-summary
stock-summary
BioHarvest Sciences, Inc.
Agricultural Commodities/Milling
BioHarvest Sciences Inc., formerly Canna-V-Cell Sciences Inc., is a Canada-based company engaged in the production and sale of a food-based nutraceutical product, VINIA. The Company’s segments include Vinia and Cannabis. Vinia segment is engaged in the development, design, manufacture and marketing of Vinia for the privet sectors. Cannabis segment is engaged in the development, design, manufacture and marketing of medical Cannabis. VINIA is manufactured by growing plant cells from red grapes in solution in Bioreactors and consists of a fine dry purple pink powder containing Piceid. The product is produced using its BioHarvest Platform Technology, which permits the growth in solution, in bioreactors, of the desired plant cells resveratrol in its natural state.
Company Coordinates stock-summary
Company Details
1140 - 625 HOWE STREET , VANCOUVER BC : V6C 2T6
stock-summary
Tel: 1 604 6221186
stock-summary
stock-summary
Registrar Details